Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Pfizer
NeoImmuneTech
Alterome Therapeutics, Inc.
ToLymph Inc.
Hoffmann-La Roche
Nuvectis Pharma, Inc.
AstraZeneca
Istituto Oncologico Veneto IRCCS
AstraZeneca
Avenzo Therapeutics, Inc.
Boehringer Ingelheim
Shanghai Pulmonary Hospital, Shanghai, China
AstraZeneca
Pheon Therapeutics
Pheon Therapeutics
Auricula Biosciences Inc.
DualityBio Inc.
Pfizer
Revolution Medicines, Inc.
Nuvation Bio Inc.